Liquidia (LQDA) Cost of Revenue (2020 - 2026)
Liquidia (LQDA) posted Cost of Revenue of $10.8 million for Q2 2026, down 2.89% on a QoQ basis from $11.1 million in Q1 2026, and up 732.74% year-over-year from $1.3 million in Q2 2025.
Analysis
Liquidia (LQDA) Cost of Revenue (2020 - 2026) Analysis & Trends
Liquidia has reported Cost of Revenue for 7 years, with the latest figure at $10.8 million in Q2 2026.
- On a quarterly basis, Cost of Revenue rose 732.74% year-over-year to $10.8 million in Q2 2026; TTM through Jun 2026 was $29.3 million, a 411.0% increase from a year earlier, with the FY2025 full-year figure at $8.8 million, up 50.09% from the prior year.
- Cost of Revenue was $10.8 million for Q2 2026 at Liquidia, down from $11.1 million in the prior quarter.
- The five-year high for Cost of Revenue was $11.1 million in Q1 2026, with the low at $570000.0 in Q3 2023.
- Average Cost of Revenue over 5 years is $2.4 million, with a median of $1.3 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2026: Cost of Revenue fell 22.97% in 2023, then jumped 732.74% in 2026.
- Over 5 years, Cost of Revenue stood at $694000.0 in 2022, then jumped by 43.08% to $993000.0 in 2023, then surged by 36.35% to $1.4 million in 2024, then jumped by 279.39% to $5.1 million in 2025, then surged by 109.44% to $10.8 million in 2026.
- The last three Cost of Revenue figures came in at $10.8 million (Q2 2026), $11.1 million (Q1 2026), and $5.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.50 Bn | 622.74 Bn | 17.26 Bn | 8.05 Bn |
| 2 | AbbVie | 440.29 Bn | 433.72 Bn | 12.70 Bn | 4.29 Bn |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | 4.40 Bn |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | 3.71 Bn |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | 4.09 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 3.51 Bn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.78 Bn | 1.57 Bn | 104.96 Mn |
| 9 | United Therapeutics | 21.42 Bn | 18.75 Bn | 683.80 Mn | 99.50 Mn |
| 10 | Liquidia | 6.09 Bn | 5.80 Bn | 160.92 Mn | 10.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.76 Mn |
| Mar 31, 2026 | 11.08 Mn |
| Dec 31, 2025 | 5.14 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 993,000.00 |
| Sep 30, 2023 | 570,000.00 |
| Jun 30, 2023 | 671,000.00 |
| Mar 31, 2023 | 654,000.00 |
| Dec 31, 2022 | 694,000.00 |
| Sep 30, 2022 | 740,000.00 |
| Jun 30, 2022 | 731,000.00 |
| Mar 31, 2022 | 694,000.00 |
| Dec 31, 2021 | 726,000.00 |
| Sep 30, 2021 | 890,000.00 |